Potential Upcoming Shifts for Diabetes-Related Diagnostic Testing

New research suggests that potential shifts might occur in diabetes-related testing, including potential increased use of point-of-care- (POC-) based hemoglobin A1c (HbA1c) testing for systematic … [Read more...]


Why Your Best Talent is Leaving and Four Ways to Win Them Back

By William A. Schiemann, Ph.D  bio Most leaders of companies today recognize the importance of having engaged people at work. Yet research from the Metrus Institute, Gallup, and others say … [Read more...]


FDA Speeding Approval Process, Continued User Fees Needed

The U.S. Food and Drug Administration (FDA) is plagued with chronic understaffing, scrutiny over the length of time for approvals, and an expanding workload, while also facing potential budget cuts … [Read more...]


Testing Recommendations Expand as Zika Season Approaches

As warm weather sets in across the southern portion of the United States, public health officials are planning for the 2017 Zika season. This mosquito year experts have a better knowledge about the … [Read more...]


Could the AHCA Slow Interest in Genetic Testing?

While it remains uncertain what the Senate will do with the American Health Care Act (AHCA), alarm is spreading about the legislation's implications for the estimated quarter of Americans under the … [Read more...]


Genomic Testing May Be Currently Overhyped, Oncologists Say

Most oncologists believe genomic testing is a major advance, but that it is "significantly overpromoted," according to a survey conducted by Medscape and the Swedish Cancer Institute in … [Read more...]


FDA Approves First-Ever, Pan-Cancer Drug in Milestone for Personalized Medicine

In what is being heralded a major milestone for personalized medicine, in late May the U.S. Food and Drug Administration (FDA) approved the first pan-cancer drug. This is the first-ever approval of a … [Read more...]


Employment Law Update for HR Managers

By Mike O'Brien  bio This is my periodic update prepared for interested HR professionals trying to deal with the complex American employment laws. Federal Appeals Court says sexual … [Read more...]


Medical Necessity Requirement Bites Anatomic Pathologists

By Robert Mazer  bio The DOJ has announced two separate settlements involving claims for allegedly unnecessary special stains. Medicare permits a pathologist to order special stains when … [Read more...]


Signs Point to Expansion of Provider-Initiated Personal Genomic Testing

Since 2013 when the U.S. Food and Drug Administration (FDA) effectively stopped direct-to-consumer personal genomic testing, there has been pent up demand among healthy individuals for testing options … [Read more...]